September 23, 2013 Comments Off on Commercial biotechnology in Latin America: Current opportunities and challenges Posted in: General Biotechnology This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Commercial biotechnology in Latin America: Current opportunities and challenges
Go to paperABSTRACT: The unparalleled growth of commercial biotechnology in…
Like this:
Like Loading...
September 23, 2013 Comments Off on Who are the most successful drug patent challengers? Posted in: General Biotechnology This chart shows the companies with the successful drug patent challenges from last year. The most successful drug patent challengers in 2012 were Mylan Pharms Inc, Lupin Pharms, Ivax Sub Teva Pharms, Teva Pharms, Perrigo Israel, Teva, Watson Labs Inc Fl, Dr Reddys Labs Ltd, Innopharma Inc, and Mylan Labs. For more infographics, see the DrugPatentWatch Pharmaceutical Innovation Infographics. Do you have a response to […]
Like this:
Like Loading...
If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
This newsletter is
a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents
Drug Patent Expirations for September 15 2013 DrugPatentWatch Serves Your Competitive Intelligence NeedsSubscribers have access to valuable datasets, including: - Patent litigation
- Clinical trial information
- International patent families
- International patent priority and PCT
information - Patent maintenance
- Full-text patent downloads
- Paragraph IV challenges
- Tentative approvals
- Drug Master Files
- Dynamic search capabilities with data
export - More…
|
The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete detailsDISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.
Like this:
Like Loading...
If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
This newsletter is
a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents
Drug Patent Expirations for September 10 2013Tradename | Applicant | Generic Name | Patent Expiration |
---|
MYRBETRIQ | Apgdi | mirabegron | Sep 10, 2013 | *Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details. |
DrugPatentWatch Serves Your Competitive Intelligence NeedsSubscribers have access to valuable datasets, including: - Patent litigation
- Clinical trial information
- International patent families
- International patent priority and PCT
information - Patent maintenance
- Full-text patent downloads
- Paragraph IV challenges
- Tentative approvals
- Drug Master Files
- Dynamic search capabilities with data
export - More…
|
The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete detailsDISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.
Like this:
Like Loading...
If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
This newsletter is
a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents
Drug Patent Expirations for September 9 2013 DrugPatentWatch Serves Your Competitive Intelligence NeedsSubscribers have access to valuable datasets, including: - Patent litigation
- Clinical trial information
- International patent families
- International patent priority and PCT
information - Patent maintenance
- Full-text patent downloads
- Paragraph IV challenges
- Tentative approvals
- Drug Master Files
- Dynamic search capabilities with data
export - More…
|
The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete detailsDISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.
Like this:
Like Loading...
If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
This newsletter is
a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents
Drug Patent Expirations for September 10 2013Tradename | Applicant | Generic Name | Patent Expiration |
---|
MYRBETRIQ | Apgdi | mirabegron | Sep 10, 2013 | *Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details. |
DrugPatentWatch Serves Your Competitive Intelligence NeedsSubscribers have access to valuable datasets, including: - Patent litigation
- Clinical trial information
- International patent families
- International patent priority and PCT
information - Patent maintenance
- Full-text patent downloads
- Paragraph IV challenges
- Tentative approvals
- Drug Master Files
- Dynamic search capabilities with data
export - More…
|
The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete detailsDISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.
Like this:
Like Loading...
If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
This newsletter is
a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents
Drug Patent Expirations for September 7 2013 DrugPatentWatch Serves Your Competitive Intelligence NeedsSubscribers have access to valuable datasets, including: - Patent litigation
- Clinical trial information
- International patent families
- International patent priority and PCT
information - Patent maintenance
- Full-text patent downloads
- Paragraph IV challenges
- Tentative approvals
- Drug Master Files
- Dynamic search capabilities with data
export - More…
|
The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete detailsDISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.
Like this:
Like Loading...
If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
This newsletter is
a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents
Drug Patent Expirations for September 2 2013 DrugPatentWatch Serves Your Competitive Intelligence NeedsSubscribers have access to valuable datasets, including: - Patent litigation
- Clinical trial information
- International patent families
- International patent priority and PCT
information - Patent maintenance
- Full-text patent downloads
- Paragraph IV challenges
- Tentative approvals
- Drug Master Files
- Dynamic search capabilities with data
export - More…
|
The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete detailsDISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.
Like this:
Like Loading...
September 11, 2013 Comments Off on Drug Patent Expirations in September 2013 Posted in: General Biotechnology Drug Patent Expirations for September 2013
Tradename
Applicant
Generic Name
Patent Number
Patent Expiration
LUPRON DEPOT
Abbvie Endocrine Inc
leuprolide acetate
5,575,987
Sep 2, 2013
LUPRON DEPOT-PED
Abbott Endocrine
leuprolide acetate
5,575,987
Sep…
Like this:
Like Loading...
September 9, 2013 Comments Off on Apply Now for the AUTM 2014 Venture Forum Posted in: General Biotechnology I will be helping judge the AUTM Venture Forum again this year. The competition features a $10,000 prize for the first-place startup company, and valuable guidance and exposure for all entrants. Full details on eligibility and benefits are at http://autmventure2014.istart.org/. The deadline for submissions is September 30, 2013.
Like this:
Like Loading...